Close Menu

NEW YORK — Drug developer Sorrento Therapeutics said on Wednesday that it has licensed a rapid point-of-care SARS-CoV-2 test from Columbia University.

According to the San Diego-based company, the reverse transcription loop-mediated isothermal amplification (RT-LAMP)-based test involves placing a saliva or nasopharyngeal swab sample into a tube that is warmed in a heat block or water bath. A colorimetric readout is provided within 30 minutes, confirming the presence or absence of viral RNA.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
12
Sponsored by
Truvian

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.